June 11, 2026 FDA Clears Home Urine Collection Kit for STI Testing The clearance enables a validated mail-in workflow for self-collected urine specimens processed on Roche cobas systems. Conexiant
June 08, 2026 FDA Expands Marstacimab Indication in Hemophilia A and B Phase 3 BASIS and BASIS KIDS data supported the expanded indication across pediatric and inhibitor-pretreated populations. Conexiant
June 04, 2026 HHS Seeks Broader Access to Health Data "We can’t do anything our agreements don’t allow us to do" Kff Health News
May 20, 2026 FDA Approves Expanded Liquid Biopsy Panel Updated liquid biopsy combines genomic and epigenomic profiling for companion diagnostic use across multiple tumor types. Conexiant
May 15, 2026 Why FDA Said No to a Melanoma Drug Questions over trial design and political pressure shadowed the rejection of Replimune’s RP1 treatment. Kff Health News
May 04, 2026 FDA Expands ASCENIV Pediatric Use Label change follows completion of required pediatric evaluation and updates prior age restrictions for treatment eligibility. Conexiant
April 30, 2026 Urgent Care, Unchecked Power An unsupervised clinic model and blurred boundaries expose how oversight can fail in outpatient care. Conexiant
April 29, 2026 FDA Reports Results of Nationwide Infant Formula Testing Federal testing survey examines chemical contaminant profiles across widely used products Conexiant
April 22, 2026 Tzield Approval Expands to Younger Patients First disease-modifying option available for children as young as 1 year with stage 2 type 1 diabetes Conexiant
April 13, 2026 FDA Flags Missing Trial Results Federal outreach seeks to improve compliance with ClinicalTrials.gov reporting requirements and make more complete clinical trial information publicly available Conexiant